Beximco Pharma completes Sanofi acquisition | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
July 10, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JULY 10, 2025
Beximco Pharma completes Sanofi acquisition

Corporates

TBS Report
01 October, 2021, 08:25 pm
Last modified: 01 October, 2021, 09:56 pm

Related News

  • Beximco Pharma contributes to Labour Welfare Foundation
  • Beximco Pharma signs MoU with North South University
  • Beximco Pharma's share price plummets 47% since July
  • Beximco Pharma unaware of reasons behind share price drop
  • How Salman F Rahman makes billions with free bank money

Beximco Pharma completes Sanofi acquisition

Sanofi Bangladesh produces approximately 100 branded generic products, mainly for the local market

TBS Report
01 October, 2021, 08:25 pm
Last modified: 01 October, 2021, 09:56 pm
Beximco Pharma MD Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque among others at Beximco’s Sanofi acquisition ceremony on Thursday. Photo: Courtesy
Beximco Pharma MD Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque among others at Beximco’s Sanofi acquisition ceremony on Thursday. Photo: Courtesy

 

Beximco Pharmaceuticals Limited, a leading manufacturer and exporter of medicine in the country, has acquired a 54.6% stake in Sanofi Bangladesh Limited. 

A brief ceremony on the occasion took place on Thursday at a hotel in Dhaka, says a press release.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The event was attended by Beximco Pharma Managing Director Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque, Secretary to Industries Ministry, SM Alam, and other senior officials from both Sanofi and Beximco.

At the event, Nazmul Hassan said, "The completion of this deal is a major milestone for us. We have a clear strategy to continue our diversification and expansion, strengthening our position as a market-leading pharma company in Bangladesh. The acquisition of a majority stake in Sanofi Bangladesh is precisely in line with this strategy."

"We look forward to welcoming over 800 skilled and diligent Sanofi Bangladesh employees into our existing workforce. As a larger group, we are excited to continue our growth trajectory, delivering affordable treatments and breakthrough therapies to our growing domestic market," he added.

There is a new 5-member board of directors, with Nazmul Hassan, Rabbur Reza and Ali Nawaz from Beximco Pharma, BCIC Chairman Imdadul Haque, and an Industries Ministry official representing the government. 

Sanofi Bangladesh is part of global biopharmaceutical company Sanofi SA. Sanofi started operating in Bangladesh in 1958 as part of May & Baker, a British chemical company. Following a series of mergers, it became known as Sanofi-Aventis in 2004, before being renamed Sanofi Bangladesh Limited in 2013.

Sanofi Bangladesh's state-of-the-art manufacturing facility is near Beximco Pharma's manufacturing facility in Tongi, producing approximately 100 branded generic products, mainly for the local market. It has a strong presence in cardiology, diabetes, oncology, and dermatology. International parent company Sanofi SA also provides its global brands of vaccines, insulins and chemotherapy drugs, directly imported by Sanofi Bangladesh.

This acquisition is the biggest in the history of the pharmaceutical industry in Bangladesh.

Economy

Beximco Pharma / Sanofi / Beximco Pharmaceuticals Limited

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • In terms of stream of education, girls maintained their excellence as well. Photo: TBS
    Lowest SSC pass rate in 17 years as over 6 lakh students fail
  • BNP Secretary General Mirza Fakhrul Islam Alamgir while speaking at a discussion at National Press Club on 10 July 2025. Photo: TBS
    'Backbone of economy will break': Fakhrul says govt should've worked seriously with more qualified people on US tariffs
  • National Consensus Commission chief Ali Riaz speaks at the Foreign Service Academy in the capital’s Bailey Road on 10 July 2025. Photo: Collected
    Chief justice appointment: Consensus reached on two key issues, says Ali Riaz

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
    Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Audit reports of most banks contain cooked up data: BB governor
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • CA orders law enforcers to complete all election preparations by December
    CA orders law enforcers to complete all election preparations by December

Related News

  • Beximco Pharma contributes to Labour Welfare Foundation
  • Beximco Pharma signs MoU with North South University
  • Beximco Pharma's share price plummets 47% since July
  • Beximco Pharma unaware of reasons behind share price drop
  • How Salman F Rahman makes billions with free bank money

Features

Illustration: TBS

Behind closed doors: Why women in Bangladesh stay in abusive marriages

1h | Panorama
Purbachl’s 144-acre Sal forest is an essential part of the area’s biodiversity. Within it, 128 species of plants and 74 species of animals — many of them endangered- have been identified. Photo: Syed Zakir Hossain/TBS

A forest saved: Inside the restoration of Purbachal's last Sal grove

1h | Panorama
Women are forced to fish in saline waters every day, risking their health to provide for their families. Photo: TBS

How Mongla’s women are bearing the brunt of rising salinity

23h | Panorama
Dr Mostafa Abid Khan. Sketch: TBS

Actual impact will depend on how US retailers respond: Mostafa Abid Khan

2d | Economy

More Videos from TBS

SSC and equivalent results released: Pass rate 68.45%, GPA drops by 5

SSC and equivalent results released: Pass rate 68.45%, GPA drops by 5

9m | TBS Today
Islami bank aims to increase deposits to Tk 2 lakh crore by 2025

Islami bank aims to increase deposits to Tk 2 lakh crore by 2025

2h | TBS Programs
The two countries still face major challenges and mutual suspicions

The two countries still face major challenges and mutual suspicions

1h | Others
RMG sector braces for impact as US tariffs hit: Fakhrul

RMG sector braces for impact as US tariffs hit: Fakhrul

2h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net